Keyphrases
Progressive multifocal Leukoencephalopathy
100%
Multiple Sclerosis
100%
Lessons Learned
100%
Natalizumab
37%
JC Virus
37%
Pathophysiology
12%
Virus
12%
Effective Treatment
12%
Immunosuppressive Therapy
12%
CNS Injury
12%
Early Detection
12%
Immune System
12%
Virus-specific
12%
Risk Stratification
12%
Associated Diseases
12%
Demyelinating Diseases
12%
Treatment Choice
12%
Molecular Biology
12%
Cellular Biology
12%
Immunocompromised Patients
12%
Human Immune System
12%
Emerging Knowledge
12%
Virus Infection
12%
Immune Parameters
12%
Severe Disabilities
12%
Improved Approach
12%
Viral Status
12%
Immune Risk Profile
12%
Immunology and Microbiology
Multiple Sclerosis
100%
JC Virus
75%
Natalizumab
75%
Immune System
50%
Virus
50%
Magnetic Resonance Imaging
25%
Viral Disease
25%
Immunity
25%
Clinically Isolated Syndrome
25%
Neuroscience
Progressive Multifocal Leukoencephalopathy
100%
Multiple Sclerosis
100%
JC Virus
37%
Natalizumab
37%
Magnetic Resonance Imaging
12%
Demyelinating Disease
12%